Monthly Archives - September 2018

Corbus Pharmaceuticals to Present at Two Upcoming Investor Conferences in October

Corbus Pharmaceuticals Holdings, Inc., a Phase 3 clinical-stage pharmaceutical company focused on the development and commercialization of novel therapeutics to treat inflammatory and fibrotic diseases by leveraging its industry leading pipeline of endocannabinoid system-targeting drug candidates, announced today that Yuval Cohen, Ph.D., Chief Executive Officer of Corbus, will present at two upcoming investor conferences in October. Read more >>

Myomo to Present at The MicroCap Conference

Myomo, Inc., a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper limb paralysis, today announced that it will be presenting at The MicroCap Conference on Monday, October 1st at 11:00 AM EDT, Track 1, Essex House in New York City. Read more >>

Corbus Pharmaceuticals Announces Presentation of Three Abstracts and New Lenabasum Data at 2018 ACR Annual Meeting

Corbus Pharmaceuticals Holdings, Inc., a Phase 3 clinical-stage pharmaceutical company focused on the development and commercialization of novel therapeutics to treat rare, chronic and serious inflammatory and fibrotic diseases, announced today that its abstracts have been selected for presentations at the American College of Rheumatology (“ACR”) 2018 Annual Meeting being held October 19-24, 2018 in Chicago, Illinois. Read more >>

Wasabi Secures $68 Million Funding Round, Bypasses Traditional VC Financing

Wasabi, the hot cloud storage company, today announces the closing of a Series B financing round totaling $68 million. Wasabi refrained from conventional venture capital, preferring instead to raise money from industry veterans and family offices. The investment is a testament to Wasabi’s progress in becoming a leading vendor of cheap, fast, and secure cloud storage. In just over a year, Wasabi has acquired more than 3,000 customers across a wide range of industries. Read more >>